Cargando…
Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma
For verifying the prognosis of Lucentis-assisted vitrectomy (PPV) in diabetic retinopathy (DR) and neovascular glaucoma (NVG), a retrospective analysis of DR and NVG patients who were admitted to our hospital from July 2019 to December 2020 was conducted. According to the treatment protocol, subject...
Autores principales: | Zhao, Xuli, Wang, Yakun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359820/ https://www.ncbi.nlm.nih.gov/pubmed/35958912 http://dx.doi.org/10.1155/2022/4127293 |
Ejemplares similares
-
Retracted: Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy
por: Kwon, Jin-woo, et al.
Publicado: (2017) -
Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
por: Sakamoto, Masashi, et al.
Publicado: (2018) -
Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study
por: Liang, Xu, et al.
Publicado: (2019) -
Pars Plana Ahmed Implantation Combined with 23-gauge Vitrectomy for Refractory Neovascular Glaucoma in Diabetic Retinopathy
por: Jeong, Hoon Seok, et al.
Publicado: (2012)